Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report

Yuzhu Mu, Ting Pan, Lingling Chen Department of Dermatology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, 215000, People’s Republic of ChinaCorrespondence: Lingling Chen, Email chenlingling031@126.comAbstract: Vitiligo and alopecia areata...

Full description

Bibliographic Details
Published in:	Clinical, Cosmetic and Investigational Dermatology
Main Authors:	Mu Y, Pan T, Chen L
Format:	Article
Language:	English
Published:	Dove Medical Press 2024-08-01
Subjects:	vitiligo alopecia areata jak inhibitor children
Online Access:	https://www.dovepress.com/treatment-of-refractory-segmental-vitiligo-and-alopecia-areata-in-a-ch-peer-reviewed-fulltext-article-CCID

Similar Items

JAK Inhibitors in Down Syndrome: Alopecia Areata Resolution and Vitiligo Improvement with Baricitinib
by: Federica Li Pomi, et al.
Published: (2025-09-01)

Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
by: He X, et al.
Published: (2024-03-01)

A Threefold Association Between Vitiligo and Alopecia Areata: Results from a Nationwide Case-control Observational Study
by: Yonit Wohl, et al.
Published: (2025-02-01)

Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
by: Ieva Lingytė, et al.
Published: (2024-09-01)

Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
by: Leah Alexandra Johnston, BSc, MD, et al.
Published: (2023-05-01)

Insights, current status and future perspective of JAK inhibitors in the treatment of alopecia areata
by: Xingqi ZHANG
Published: (2022-04-01)

Survey of pediatric dermatologist views on treatment for alopecia areata
by: David Bitterman, BA, et al.
Published: (2023-12-01)

Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
by: Siddhi B. Chikhalkar, et al.
Published: (2024-06-01)

The Importance of Readability: A Guide to Understanding Alopecia Areata through Multilingual Online Resources
by: Tomasz Skrzypczak, et al.
Published: (2024-11-01)

The Relationship Between Vitamin D Levels and the Quality of Life in Patients with Alopecia Areata and Vitiligo
by: Nazlı Dizen Namdar, et al.
Published: (2019-04-01)

Type D personality and quality of life in alopecia areata and vitiligo patients: A cross-sectional study in a Turkish population
by: Güldehan Atış, et al.
Published: (2021-06-01)

Pathogenesis and regenerative therapy in vitiligo and alopecia areata: focus on hair follicle
by: Yuan Zhou, et al.
Published: (2025-01-01)

Effective treatment of alopecia universalis with oral upadacitinib
by: Soundos Youssef, MD, et al.
Published: (2023-01-01)

Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review
by: Dianhe Yu, et al.
Published: (2023-04-01)

Strategies for Managing Suboptimal Response to JAK Inhibitors in Alopecia Areata
by: S. Morteza Seyed Jafari, et al.
Published: (2025-08-01)

Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
by: Sofia Faria, et al.
Published: (2023-09-01)

Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
by: Yijia He, et al.
Published: (2025-04-01)

Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
by: Mariko Niki, et al.
Published: (2025-12-01)

Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
by: C. Perricone, et al.
Published: (2024-10-01)

Alopecia areata: from pathophysiology to therapeutic innovation
by: Nuno Lourenço, et al.
Published: (2023-04-01)

Modern Management Approaches for Alopecia Areata
by: Eduard T. Ambarchyan, et al.
Published: (2024-12-01)

Jak inhibitors in the treatment of alopecia areata - a literature review
by: Paulina Krzeszowska, et al.
Published: (2025-06-01)

Effective use of oral tofacitinib and phototherapy in a patient with concomitant alopecia areata, vitiligo, and plaque and inverse psoriasis
by: Mahroo Tajalli, et al.
Published: (2020-05-01)

FR - Actualización en el tratamiento de la alopecia areata
by: E.L. Pinto-Pulido, et al.
Published: (2025-04-01)

Successful treatment of a case of dupilumab-induced psoriasis and alopecia areata with tofacitinib
by: SUN Feifei, et al.
Published: (2025-06-01)

Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
by: Sihan Wang, et al.
Published: (2025-01-01)

Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
by: Sarah Choe, et al.
Published: (2024-01-01)

Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review
by: Gao Y, et al.
Published: (2025-09-01)

Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study
by: Jundong Huang, et al.
Published: (2023-11-01)

Inhibition of T-cell activity in alopecia areata: recent developments and new directions
by: Thierry Passeron, et al.
Published: (2023-11-01)

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
by: Maddison Lensing, et al.
Published: (2022-08-01)

Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
by: Olivia Katamanin, BS, et al.
Published: (2024-01-01)

Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
by: Matteini E, et al.
Published: (2024-10-01)

Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
by: Farnam Barati Sedeh, et al.
Published: (2023-01-01)

[Translated article] RF – An Update on the Management of Alopecia Areata
by: E.L. Pinto-Pulido, et al.
Published: (2025-04-01)

Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
by: Carlo A. Vignoli, et al.
Published: (2025-12-01)

The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
by: Diqin Yan, et al.
Published: (2022-08-01)

Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
by: Lucia Peterle, et al.
Published: (2023-01-01)

Alopecia Areata Incognita: Current Evidence
by: Giselle Rodríguez-Tamez, et al.
Published: (2025-02-01)

Retrospective analysis of tofacitinib in the treatment of moderate to severe alopecia areata
by: WANG Fujun, et al.
Published: (2025-09-01)